Transfection of promyelocytic leukemia in retrovirus vector inhibits growth of human bladder cancer cells

Acta Pharmacologica Sinica

Volumn 26, Issue 5, 2005, Pages 610-615

  Li, Lei ^a   He, Da Lin ^a  

^a NONE

Author keywords

Gene therapy; Promyelocytic leukemia protein; Retrovirus

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CALCIUM PHOSPHATE; COMPLEMENTARY DNA; PLASMID VECTOR; PROMYELOCYTIC LEUKEMIA PROTEIN; RESTRICTION ENDONUCLEASE; RETROVIRUS VECTOR;

ARTICLE; BASE PAIRING; BLADDER CANCER; CANCER CELL CULTURE; CANCER GENETICS; CANCER GROWTH; CELL NUCLEUS; CELL STRAIN 3T3; CELL STRAIN PA317; CELL STRUCTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; FLUORESCENCE; GENE INSERTION; GENETIC TRANSFECTION; GROWTH CURVE; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MOLECULAR WEIGHT; PHASE CONTRAST MICROSCOPE; PLASMID LXSN; POLYMERASE CHAIN REACTION; PRECIPITATION; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA GENE; PROTEIN ANALYSIS; RESTRICTION MAPPING; TUMOR SUPPRESSOR GENE; VIRUS RECOMBINANT; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL PROLIFERATION; DNA, COMPLEMENTARY; GENE THERAPY; GENETIC VECTORS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 18744403726     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00065.x     Document Type: Article

References (17)

1. Mu ZM, Chin KV, Liu JH, Lozano G, Chang KS. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 1994; 14: 6858-67.
2. Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R, et al. PML is essential for multiple apoptotic pathways. Nat Genet 1998; 20: 266-72.
3. Koken MH, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thepot J, et al. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 1995; 10: 1315-24.
4. Mu ZM, Le XF, Vallian S, Glassman AB, Chang KS. Table overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 1997; 18: 2063-9.
5. He D, Mu ZM, Le X, Hsieh JT, Pong RC, Chung LW, et al. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells. Cancer Res 1997; 57: 1868-72.
6. Le XF, Vallian S, Mu ZM, Hung MC, Chang KS. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 1998; 16: 1839-49.
7. He D, Nan X, Chang KS, Wang Y, Chung LW Overexpression of the promyelocytic leukemia gene suppresses growth of human bladder cancer cells by inducing G1 cell cycle arrest and apoptosis. Chin Med J 2003; 116: 1394-8.
8. Grossman HB, Wedemeyer G, Ren L. UM-UC-1 and UM-UC-2: characterization of two new human transitional cell carcinoma lines. J Urol 1984; 132: 834-7.
9. Jseph S, Daivd WR. Laboratory manual. 3rd ed. Cold Spring, NY: Cold Spring Laboratory; 2001. p 1282-6.
10. Miller AD, Miller DG, Garcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Methods Enzymol 1993; 217: 581-99.
11. Bodine DM, McDonagh KT, Seidel NE, Nienhuis AW. Development of a high-liter retrovirus producer cell line and strategies for retrovirus-mediated gene transfer into rhesus monkey hematopoietic stem cells. Ann N Y Acad Sci 1990; 612: 415-26.
12. Friedmann T. Progress toward human gene therapy. Science 1989; 244: 1275-81.
13. Sokol DL, Gewirtz AM. Gene therapy: basic concepts and recent advances. Crit Rev Eukaryot Gene Expr 1996; 6: 29-57.
14. Shayakhmetov DM, Li ZY, Ni S, Lieber A. Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases. Cancer Res 2002; 62: 1063-8.
15. Li Y, Pong RC, Bergelson JM, Hall MC, Sagalowsky AI, Tseng CP, et al. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 1999; 59: 325-30.
16. Rauen KA, Sudilovsky D, Le JL, Chew KL, Hann B, Weinberg V, et al. Expression of the Coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res 2002; 62: 3812-8.
17. Kasono K, Blackwell JL, Douglas JT, Dmitriev I, Strong TV, Reynolds P, et al. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector. Clin Cancer Res 1999; 5: 2571-9.